Code & Cure - Episode 8: Digital hearts - The future of cardiovascular medicine

glossary_cover_8_Youtube_1280x720

Heart diseases are the leading cause of death worldwide, with conditions like arrhythmia and atrial fibrillation often requiring implanted devices such as pacemakers and occluders. Discover how in silico medicine enables clinicians to virtually test these devices, optimising selection and improving surgical precision.

Gallery:

glossary_cover_8_Youtube_1280x720
Tag: | Video: 8 of 8
All video

News

  • 31/03/2025

    VPHi submits MDR Revision Proposals to the European Commission

    • The VPH Institute calls for MDR evaluation to leverage computer modelling and simulation methodologies, including AI, to mitigate current challenges and prepare for future needs. -Read more-
  • 31/03/2025

    EMA qualifies first artificial intelligence tool to diagnose inflammatory liver disease (MASH) in biopsy samples

    • The European Medicines Agency (EMA) offered a positive opinion last week on a new artificial intelligence (AI)ā€“based tool that supports pathologists in diagnosing and assessing the severity of metabolic dysfunctionā€“associated steatohepatitis (MASH) during clinical trials. -Read more-
  • 27/03/2025

    VPHi participates in InnovaHeart 2025 workshop to advance Digital Cardiac Care

    • With around 60 participants among cardiologists, regulatory bodies and scientists, the event sparked insightful discussions on the latest advancements in cardiovascular digital twins. -Read more-
  • 26/03/2025

    Cancer virtual twins presented at the 9th Annual Conference of the Hellenic Cancer Federation

    • From 3 to 5 February 2025, the 9th Annual Conference of the Hellenic Cancer Federation (ELLOK) took place in Athens (Greece). -Read more-
More news

Events

More events
newsletter

Subscribe to the VPH Institute Newsletter

ARCHIVE

Read all the newsletters of the VPH Institute

GO